Literature DB >> 22936126

Benefits of a self-management program in low-income African-American women with systemic lupus erythematosus: results of a pilot test.

C Drenkard1, C Dunlop-Thomas, K Easley, G Bao, T Brady, S S Lim.   

Abstract

Minorities with systemic lupus erythematosus (SLE) are at high risk of poor disease outcomes and may face challenges in effectively self-managing multiple health problems. The Chronic Disease Self-Management Program (CDSMP) is an evidence-based intervention that improves the health of people with chronic illnesses. Although the CDSMP is offered by organizations throughout the United States and many countries around the world, it has not been tested among SLE patients. We pilot tested the benefits of the CDSMP in low-income African American patients with SLE. CDSMP workshops were delivered to 49 African American women with SLE who received medical care at a public lupus clinic in Atlanta, Georgia, US. We compared pre-post CDSMP changes (from baseline to 4 months after the start of the intervention) in health status, self-efficacy and self-management behaviors using self-reported measures. Additionally, we assessed health care utilization changes using electronic administrative records in the 6-month periods before and after the intervention. We observed significant improvements post-intervention in the SF-36 physical health component summary (mean change = 2.4, p = 0.032); self-efficacy (mean change = 0.5, p = 0.035); and several self-management behaviors: cognitive symptoms management (mean change = 0.3, p = 0.036); communication with physicians (mean change = 0.4, p = 0.01); and treatment adherence (mean change = 0.4, p = 0.01). The median number of outpatient visits decreased from 3 to 1 (p < .0001). The CDSMP is a promising intervention for low-income African Americans with SLE. It is an inexpensive program with growing availability around the world that should be further evaluated as a resource to improve patient-centered outcomes and decrease health service utilization among SLE patients.

Entities:  

Mesh:

Year:  2012        PMID: 22936126     DOI: 10.1177/0961203312458842

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  15 in total

1.  Relationship Between Process of Care and a Subsequent Increase in Damage in Systemic Lupus Erythematosus.

Authors:  Edward Yelin; Jinoos Yazdany; Laura Trupin
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-05-09       Impact factor: 4.794

Review 2.  Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus.

Authors:  Carol M Greco; Claire Nakajima; Susan Manzi
Journal:  Curr Rheumatol Rep       Date:  2013-11       Impact factor: 4.592

Review 3.  A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases.

Authors:  Hendra Goh; Yu Heng Kwan; Yi Seah; Lian Leng Low; Warren Fong; Julian Thumboo
Journal:  Rheumatol Int       Date:  2017-07-05       Impact factor: 2.631

4.  Factors Associated with the Initiation and Retention of Patients with Lupus in the Chronic Disease Self-Management Program.

Authors:  Titilola Falasinnu; Gaobin Bao; Teresa J Brady; S Sam Lim; Cristina Drenkard
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-11-04       Impact factor: 5.178

5.  Association of Poverty Income Ratio with Physical Functioning in a Cohort of Patients with Systemic Lupus Erythematosus.

Authors:  Courtney Hoge; C Barrett Bowling; S Sam Lim; Cristina Drenkard; Laura C Plantinga
Journal:  J Rheumatol       Date:  2020-03-01       Impact factor: 4.666

6.  Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Authors:  John G Hanly; Qiuju Li; Li Su; Murray B Urowitz; Caroline Gordon; Sang-Cheol Bae; Juanita Romero-Diaz; Jorge Sanchez-Guerrero; Sasha Bernatsky; Ann E Clarke; Daniel J Wallace; David A Isenberg; Anisur Rahman; Joan T Merrill; Paul Fortin; Dafna D Gladman; Ian N Bruce; Michelle Petri; Ellen M Ginzler; M A Dooley; Kristjan Steinsson; Rosalind Ramsey-Goldman; Asad A Zoma; Susan Manzi; Ola Nived; Andreas Jonsen; Munther A Khamashta; Graciela S Alarcón; Winn Chatham; Ronald F van Vollenhoven; Cynthia Aranow; Meggan Mackay; Guillermo Ruiz-Irastorza; Manuel Ramos-Casals; S Sam Lim; Murat Inanc; Kenneth C Kalunian; Soren Jacobsen; Christine A Peschken; Diane L Kamen; Anca Askanase; Chris Theriault; Vernon Farewell
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-09-01       Impact factor: 4.794

7.  Health service utilization among African American women living with systemic lupus erythematosus: perceived impacts of a self-management intervention.

Authors:  Abena A Twumasi; Anna Shao; Charmayne Dunlop-Thomas; Cristina Drenkard; Hannah L F Cooper
Journal:  Arthritis Res Ther       Date:  2019-06-25       Impact factor: 5.156

8.  Patient Perspective on Using Digital Resources to Address Unmet Needs in Systemic Lupus Erythematosus.

Authors:  Jennifer H Ra; Jerik Leung; Elizabeth A Baker; Alfred H J Kim
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-09-08       Impact factor: 5.178

9.  Prolonged improvement of childhood onset systemic lupus erythematosus following systematic administration of rituximab and cyclophosphamide.

Authors:  Thomas Ja Lehman; Chahait Singh; Anusha Ramanathan; Risa Alperin; Alexa Adams; Laura Barinstein; Nandini Moorthy
Journal:  Pediatr Rheumatol Online J       Date:  2014-01-14       Impact factor: 3.054

Review 10.  I too, am America: a review of research on systemic lupus erythematosus in African-Americans.

Authors:  Edith M Williams; Larisa Bruner; Alyssa Adkins; Caroline Vrana; Ayaba Logan; Diane Kamen; James C Oates
Journal:  Lupus Sci Med       Date:  2016-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.